Quarterly report · Q1
6856.TEDINET S100QR7T
Period2023-01-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥65.9bn | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥270.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥55.5bn | 2022-01-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥10.4bn | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥8.6bn | 2022-01-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥10.3bn | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥46.9bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.7bn | 2022-01-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥16.4bn | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥8.7bn | 2022-01-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥13.6bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥34.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.7bn | 2022-01-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥13.6bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥5.7bn | 2022-01-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥414.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥416.7bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥382.2bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥164.9bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥175.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥249.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥240.8bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥211.3bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥125.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥139.9bn | at 2022-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥320.99 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥807.06 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥135.59 | 2022-01-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥319.36 | 2023-01-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥802.89 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥134.88 | 2022-01-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 60.0% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥15.9bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥15.9bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥330m |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥7.4bn |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥7.4bn |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥43m |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥5.4bn |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥5.4bn |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥529m |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥73m |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥29.0bn |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥29.0bn |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥9.7bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥13.7bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥13.7bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥133m |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥6.7bn |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥6.7bn |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥154m |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥4.8bn |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥4.8bn |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥453m |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥683m |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥22.2bn |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥22.2bn |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥7.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 398
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 15860000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | -0 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 5000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E01901-000AutomotiveTestSystemsReportableSegmentsMember | 13675000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E01901-000ProcessAndEnvironmentalInstrumentsAndSystemsReportableSegmentsMember | 4788000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E01901-000MedicalDiagnosticInstrumentsAndSystemsReportableSegmentsMember | 6650000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E01901-000SemiconductorInstrumentsAndSystemsReportableSegmentsMember | 22225000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E01901-000ScientificInstrumentsAndSystemsReportableSegmentsMember | 8169000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 55510000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E01901-000AutomotiveTestSystemsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E01901-000ProcessAndEnvironmentalInstrumentsAndSystemsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E01901-000MedicalDiagnosticInstrumentsAndSystemsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E01901-000SemiconductorInstrumentsAndSystemsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E01901-000ScientificInstrumentsAndSystemsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E01901-000AutomotiveTestSystemsReportableSegmentsMember | 13675000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E01901-000ProcessAndEnvironmentalInstrumentsAndSystemsReportableSegmentsMember | 4788000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E01901-000MedicalDiagnosticInstrumentsAndSystemsReportableSegmentsMember | 6650000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E01901-000SemiconductorInstrumentsAndSystemsReportableSegmentsMember | 22225000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E01901-000ScientificInstrumentsAndSystemsReportableSegmentsMember | 8169000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 55510000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E01901-000AutomotiveTestSystemsReportableSegmentsMember | 133000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E01901-000ProcessAndEnvironmentalInstrumentsAndSystemsReportableSegmentsMember | 453000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E01901-000MedicalDiagnosticInstrumentsAndSystemsReportableSegmentsMember | 154000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E01901-000SemiconductorInstrumentsAndSystemsReportableSegmentsMember | 7180000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E01901-000ScientificInstrumentsAndSystemsReportableSegmentsMember | 683000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1YTDDuration | 8605000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E01901-000AutomotiveTestSystemsReportableSegmentsMember | 15943000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E01901-000ProcessAndEnvironmentalInstrumentsAndSystemsReportableSegmentsMember | 5404000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E01901-000MedicalDiagnosticInstrumentsAndSystemsReportableSegmentsMember | 7351000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E01901-000SemiconductorInstrumentsAndSystemsReportableSegmentsMember | 28988000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E01901-000ScientificInstrumentsAndSystemsReportableSegmentsMember | 8166000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 65854000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E01901-000AutomotiveTestSystemsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E01901-000ProcessAndEnvironmentalInstrumentsAndSystemsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E01901-000MedicalDiagnosticInstrumentsAndSystemsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E01901-000SemiconductorInstrumentsAndSystemsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E01901-000ScientificInstrumentsAndSystemsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E01901-000AutomotiveTestSystemsReportableSegmentsMember | 15943000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E01901-000ProcessAndEnvironmentalInstrumentsAndSystemsReportableSegmentsMember | 5404000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E01901-000MedicalDiagnosticInstrumentsAndSystemsReportableSegmentsMember | 7351000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E01901-000SemiconductorInstrumentsAndSystemsReportableSegmentsMember | 28988000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E01901-000ScientificInstrumentsAndSystemsReportableSegmentsMember | 8166000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |